Virtual Clinical Trials Market Segmentation
Virtual Clinical Trials Study Type Outlook (USD Billion, 2018-2030)
Interventional
Observational
Others
Virtual Clinical Trials Phase Outlook (USD Billion, 2018-2030)
Phase 1
Phase 2
Phase 3
Phase 4
Virtual Clinical Trials Indication Outlook (USD Billion, 2018-2030)
Oncology
Cardiovascular
Immunology
Gastrointestinal
Respiratory
Endocrinology
Ophthalmology
Others
Virtual Clinical Trials Regional Outlook (USD Billion, 2018-2030)
North America Outlook (USD Billion, 2018-2030)
Interventional
Observational
Others
US Virtual Clinical Trials by Phase
Phase 1
Phase 2
Phase 3
Phase 4
US Virtual Clinical Trials by Indication
Oncology
Cardiovascular
Immunology
Gastrointestinal
Respiratory
Endocrinology
Ophthalmology
Others
Canada Outlook (USD Billion, 2018-2030)
Europe Outlook (USD Billion, 2018-2030)
France Outlook (USD Billion, 2018-2030)
Respiratory
China Outlook (USD Billion, 2018-2030)
Japan Outlook (USD Billion, 2018-2030)
South Korea Outlook (USD Billion, 2018-2030)
Rest of the World Outlook (USD Billion, 2018-2030)
Research Methodology on the Virtual Clinical Trials Market
Introduction
In recent years, the healthcare industry has witnessed significant changes due to advances in technology, leading to the introduction of virtual clinical trials. Virtual clinical trials are electronic versions of clinical trials which allow data collection and patient follow-up by remote means. This new methodology results in a faster research process, reduced costs and timeline, improved patient compliance, better accuracy of data, and similar outcomes to traditional on-site trials. An in-depth and detailed understanding of the industry provides valuable information to both marketers and prospective investors.
In this research report, Market Research Future (MRFR) has endeavoured to provide an insightful take on the global virtual clinical trials market and its various related aspects. The research report is multi-faceted and considers market trends, in-depth market analysis and forecasts until 2030. The key players, along with their market share, strategies, and regional growth analysis, have also been studied in detail in the report.
Research Methodology
The research methodologies adopted for this research are primary and secondary research, wherein both qualitative and quantitative data were gathered from the entire chain of the virtual clinical trials market to determine the current market scenario, future trends, growth opportunities and limitations.
In the primary research methodology, in-depth expert interviews are conducted, with healthcare experts and other participants at medical facilities such as hospitals and clinical trial centres. During the interviews, information was gathered along with opinions, views and suggestions. In the secondary research, market research reports, accumulated data sets through financial reports, industry magazines and white papers, focus group discussions and other databases were considered.
The secondary source includes Factiva, one source, Bloomberg, Hoovers, Manta and other databases from the private sector and the public sector, CMOS, CBIP, and statistical data from RTIS.
To address the report in a systematic approach, PESTLE tools and Porter’s Five Forces analysis framework were adopted. These tools provide an in-depth analysis of the emerging trends and lucrative opportunities in the market.
Market Segmentation
The virtual clinical trials market is segmented based on product type, end-user, and region.
By product type, the global virtual clinical trials market is segmented into clinical trial software systems, patient engagement systems, and data management systems.
By end user, the global virtual clinical trials market is segmented into pharmaceutical companies, contract research organizations, and research and academic institutes.
By region, the global virtual clinical trials market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
Market Players
Notable players in the global virtual clinical trials market include Medidata Solutions, Inc. (U.S.), Parexel International Corporation (U.S.), ArunA Biomedical (U.S.), Oracle Corporation (U.S.), Webmedx Inc. (U.S.), ERT Clinical (U.S.), DATATRAK International (U.S.), eClinical Solutions (U.S.), OmniComm Systems, Inc. (U.S.), and Biotrial S.A.S. (France).
Data Collection
To understand and analyze the market, the data collection phase is done. Primary and secondary data is collected by data collection tools such as structured questionnaires, surveys, interviews and focus group discussions. Maynard, Anderson and BCG portfolio analysis techniques are used to identify the categories of virtual clinical trial products and services.
A structured questionnaire survey is conducted with key players and stakeholders in the virtual clinical trials market to collect primary data. For the secondary research, content analysis of various virtual clinical trial market reports was done.
Data Analysis
Data analysis is done to track market trends and performance. This includes the analysis of macro and microeconomic factors, market drivers and restraints, trends and opportunities, and the competitive landscape. The market dynamics analysis is done based on industry trends, drivers and opportunities. Porter’s Five Forces analysis tool is used to understand the industry dynamics and competition among the existing players.
The market size and forecast are conducted by using the top-down and bottom-up approaches. This involves deriving the estimated data from micro and macro factors and further used to validate the market size from primary sources.
Finally, the data is triangulated using data triangulation techniques to get a more accurate and reliable estimate of the market size.
Conclusion
This report is a comprehensive analysis of the global virtual clinical trials market and provides an in-depth understanding of the various factors driving the growth of the industry. The report also contains a detailed analysis of the competitive landscape, key players and their strategies, market segmentation, market dynamics, and forecast until 2030. The report will be valuable to market-oriented investors and stakeholders already in the industry.
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on R&D
5.3.3. Regional Impact
5.3.4. Impact on Market Growth
6. GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE
6.1. Overview
6.2. Interventional
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
6.3. Observational
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
6.4. Others
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
7. GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY PHASE
7.1. Overview
7.2. Phase 1
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
7.3. Phase 2
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
7.4. Phase 3
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
7.5. Phase 4
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
8. GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION
8.1. Overview
8.2. Oncology
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
8.3. Cardiovascular
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
8.4. Immunology
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
8.5. Gastrointestinal
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
8.6. Respiratory
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
8.7. Endocrinology
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
8.8. Ophthalmology
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
8.9. Others
Market Estimates & Forecast, by Region, 2018–2027
Market Estimates & Forecast, by Country, 2018–2027
9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY REGION
9.1. Overview
9.2. North America
9.2.1. US
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. Italy
9.3.4. Spain
9.3.5. UK
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Virtual Clinical Trials Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Virtual Clinical Trials Market
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2020
10.8.2. Major Players R&D Expenditure, 2020
11. COMPANY PROFILES
11.1. Oracle Corporation
11.1.1. Company Overview
11.1.2. Products Offered
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. IQVIA Holdings, Inc.
11.2.1. Company Overview
11.2.2. Products Offered
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Dassault Systemes SE
11.3.1. Company Overview
11.3.2. Products Offered
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Medpace Holdings, Inc.
11.4.1. Company Overview
11.4.2. Products Offered
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Icon plc
11.5.1. Company Overview
11.5.2. Products Offered
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Laboratory Corporation of America Holdings
11.6.1. Company Overview
11.6.2. Products Offered
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Parexel International Corporation
11.7.1. Company Overview
11.7.2. Products Offered
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Medable, Inc.
11.8.1. Company Overview
11.8.2. Products Offered
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Clinical Ink, Inc.
11.9.1. Company Overview
11.9.2. Products Offered
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Wuxi AppTech
11.10.1. Company Overview
11.10.2. Products Offered
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Syneos Health
11.11.1. Company Overview
11.11.2. Products Offered
11.11.3. Financial Overview
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SYNOPSIS, 2018–2027
TABLE 2 GLOBAL VIRTUAL CLINICAL TRIALS MARKET ESTIMATES & FORECAST, 2018–2027 (USD MILLION)
TABLE 3 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 4 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 5 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 6 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 7 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 8 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 9 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 10 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 11 US: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 12 US: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 13 US: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 14 CANADA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 15 CANADA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 16 CANADA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 17 EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 18 EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 19 EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 20 EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 21 GERMANY: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 22 GERMANY: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 23 GERMANY: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 24 UK: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 25 UK: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 26 UK: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 27 FRANCE: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 28 FRANCE: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 29 FRANCE: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 30 ITALY: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 31 ITALY: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 32 ITALY: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 33 SPAIN: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 34 SPAIN: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 35 SPAIN: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 36 REST OF EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 37 REST OF EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 38 REST OF EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 39 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 40 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 41 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 42 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 43 INDIA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 44 INDIA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 45 INDIA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 46 CHINA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 47 CHINA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 48 CHINA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 49 JAPAN: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 50 JAPAN: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 51 JAPAN: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 52 SOUTH KOREA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 53 SOUTH KOREA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 54 SOUTH KOREA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 55 AUSTRALIA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 56 AUSTRALIA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 57 AUSTRALIA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 58 REST OF ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 59 REST OF ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 60 REST OF ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 61 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 62 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 63 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 64 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 65 MIDDLE EAST: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 66 MIDDLE EAST: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 67 MIDDLE EAST: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 68 AFRICA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 69 AFRICA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 70 AFRICA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
TABLE 71 LATIN AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018–2027 (USD MILLION)
TABLE 72 LATIN AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018–2027 (USD MILLION)
TABLE 73 LATIN AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018–2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL VIRTUAL CLINICAL TRIALS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL VIRTUAL CLINICAL TRIALS MARKET
FIGURE 4 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE, BY STUDY TYPE, 2020 (%)
FIGURE 5 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE, BY PHASE, 2020 (%)
FIGURE 6 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE, BY INDICATION, 2020 (%)
FIGURE 7 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 EUROPE: VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 12 GLOBAL VIRTUAL CLINICAL TRIALS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 13 ORACLE CORPORATION: KEY FINANCIALS
FIGURE 14 ORACLE CORPORATION: SWOT ANALYSIS
FIGURE 15 IQVIA HOLDINGS, INC.: KEY FINANCIALS
FIGURE 16 IQVIA HOLDINGS, INC.: SWOT ANALYSIS
FIGURE 17 DASSAULT SYSTEMES SE: KEY FINANCIALS
FIGURE 18 DASSAULT SYSTEMES SE: SWOT ANALYSIS
FIGURE 19 MEDPACE HOLDINGS, INC.: KEY FINANCIALS
FIGURE 20 MEDPACE HOLDINGS, INC.: SWOT ANALYSIS
FIGURE 21 ICON PLC: KEY FINANCIALS
FIGURE 22 ICON PLC: SWOT ANALYSIS
FIGURE 23 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY FINANCIALS
FIGURE 24 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS
FIGURE 25 PAREXEL INTERNATIONAL CORPORATION: KEY FINANCIALS
FIGURE 26 PAREXEL INTERNATIONAL CORPORATION: SWOT ANALYSIS
FIGURE 27 MEDABLE, INC.: KEY FINANCIALS
FIGURE 28 MEDABLE, INC.: SWOT ANALYSIS
FIGURE 29 CLINICAL INK, INC.: KEY FINANCIALS
FIGURE 30 CLINICAL INK, INC.: SWOT ANALYSIS
FIGURE 31 WUXI APPTECH: KEY FINANCIALS
FIGURE 32 WUXI APPTECH: SWOT ANALYSIS
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
